Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma.

Shah US, Dhir R, Gollin SM, Chandran UR, Lewis D, Acquafondata M, Pflug BR.

Hum Pathol. 2006 Apr;37(4):401-9. Epub 2006 Feb 7.

PMID:
16564913
2.

Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.

Schmidt LJ, Ballman KV, Tindall DJ.

Prostate. 2007 Jul 1;67(10):1111-20.

PMID:
17477363
3.

Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.

Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP.

Cancer Biol Ther. 2007 Aug;6(8):1263-8. Epub 2007 May 17.

PMID:
17786030
4.

High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.

Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS.

Am J Gastroenterol. 2009 Jul;104(7):1790-801. doi: 10.1038/ajg.2009.230. Epub 2009 Jun 2.

PMID:
19491830
5.

KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.

Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS.

Biochem J. 2009 Jan 1;417(1):313-22. doi: 10.1042/BJ20080762.

PMID:
18774944
6.

Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.

Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, Garcia-Villalba R, Carrasco-Pancorbo A, Fernandez-Gutierrez A, Segura-Carretero A.

Int J Mol Med. 2008 Oct;22(4):433-9.

PMID:
18813848
7.

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Schlomm T, Kirstein P, Iwers L, Daniel B, Steuber T, Walz J, Chun FH, Haese A, Kollermann J, Graefen M, Huland H, Sauter G, Simon R, Erbersdobler A.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6579-84.

8.

Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M.

Mol Cancer Res. 2003 Aug;1(10):707-15.

9.

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.

Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA.

Cell Prolif. 2008 Feb;41(1):59-85. doi: 10.1111/j.1365-2184.2007.00498.x.

PMID:
18211286
11.

Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.

Mark HF, Samy M, Santoro K, Mark S, Feldman D.

Exp Mol Pathol. 2000 Feb;68(1):65-9.

PMID:
10640455
12.

Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue.

Jensen KC, Schaeffer DF, Cheang M, Montgomery K, West RB, Gilks CB, Ross D, Turashvili G, Schnitt S, van de Rijn M.

Mod Pathol. 2008 Dec;21(12):1413-20. doi: 10.1038/modpathol.2008.163. Epub 2008 Sep 26.

13.

A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction.

Liu H, Liu Y, Zhang JT.

Mol Cancer Ther. 2008 Feb;7(2):263-70. doi: 10.1158/1535-7163.MCT-07-0445.

14.

Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.

Sanchez KM, Sweeney CJ, Mass R, Koch MO, Eckert GJ, Geary WA, Baldridge LA, Zhang S, Eble JN, Cheng L.

Cancer. 2002 Oct 15;95(8):1650-5.

15.

Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.

Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F.

Oncogene. 2006 Apr 27;25(18):2628-35.

PMID:
16369491
16.

Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer.

Doak SH, Jenkins SA, Hurle RA, Varma M, Hawizy A, Kynaston HG, Parry JM.

Cancer Genet Cytogenet. 2007 Jul 15;176(2):161-5.

PMID:
17656261
17.
18.

Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase.

Xiao R, Su Y, Simmen RC, Simmen FA.

Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G868-76. doi: 10.1152/ajpgi.00515.2007. Epub 2008 Jan 31.

19.

Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.

Williams K, Fernandez S, Stien X, Ishii K, Love HD, Lau YF, Roberts RL, Hayward SW.

Prostate. 2005 Jun 1;63(4):369-84.

PMID:
15937962
20.

HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A.

Hum Pathol. 2006 Sep;37(9):1137-44. Epub 2006 Jun 21.

PMID:
16938518

Supplemental Content

Support Center